HUP9801629A3 - Methods and compositions for regulation of cd28 expression - Google Patents
Methods and compositions for regulation of cd28 expressionInfo
- Publication number
- HUP9801629A3 HUP9801629A3 HU9801629A HUP9801629A HUP9801629A3 HU P9801629 A3 HUP9801629 A3 HU P9801629A3 HU 9801629 A HU9801629 A HU 9801629A HU P9801629 A HUP9801629 A HU P9801629A HU P9801629 A3 HUP9801629 A3 HU P9801629A3
- Authority
- HU
- Hungary
- Prior art keywords
- regulation
- expression
- compositions
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38704195A | 1995-02-09 | 1995-02-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9801629A2 HUP9801629A2 (en) | 1998-10-28 |
HUP9801629A3 true HUP9801629A3 (en) | 2000-10-30 |
Family
ID=23528194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801629A HUP9801629A3 (en) | 1995-02-09 | 1996-02-05 | Methods and compositions for regulation of cd28 expression |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0810882A4 (en) |
HU (1) | HUP9801629A3 (en) |
PL (1) | PL321711A1 (en) |
WO (1) | WO1996024380A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
IT1277025B1 (en) * | 1995-12-04 | 1997-11-04 | Cooperativa Centro Ricerche Po | CLASS OF PHOSPHODIESTERIC OLIGONUCLEOTIDES WITH CYTOTOXIC ACTIVITY PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE |
EP0968226A4 (en) * | 1996-12-27 | 2001-02-14 | Icn Pharmaceuticals | G-rich oligo aptamers and methods of modulating an immune response |
CA2341338A1 (en) * | 1998-09-03 | 2000-03-16 | Coley Pharmaceutical Gmbh | G-motif oligonucleotides and uses thereof |
WO2002022809A2 (en) | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
KR101801407B1 (en) * | 2009-07-24 | 2017-11-24 | 큐알엔에이, 인크. | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
JP6175236B2 (en) | 2009-09-25 | 2017-08-09 | カッパーアールエヌエー,インコーポレイテッド | Treatment of FLG-related diseases by modulating the expression and activity of filaggrin (FLG) |
WO2014090985A1 (en) * | 2012-12-13 | 2014-06-19 | Universität Leipzig | T-cell modulation by exon skipping |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015671A1 (en) * | 1991-03-08 | 1992-09-17 | Cytomed, Inc. | Soluble cd28 proteins and methods of treatment therewith |
US6664107B1 (en) * | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
-
1996
- 1996-02-05 PL PL96321711A patent/PL321711A1/en unknown
- 1996-02-05 HU HU9801629A patent/HUP9801629A3/en unknown
- 1996-02-05 EP EP96909477A patent/EP0810882A4/en not_active Withdrawn
- 1996-02-05 WO PCT/US1996/001507 patent/WO1996024380A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9801629A2 (en) | 1998-10-28 |
EP0810882A1 (en) | 1997-12-10 |
PL321711A1 (en) | 1997-12-22 |
EP0810882A4 (en) | 1999-05-19 |
WO1996024380A1 (en) | 1996-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5529596A (en) | Methods and compositions related to stereolithography | |
IL117872A0 (en) | Herbicidal compositions and method of their use | |
AU7471096A (en) | Compositions and methods for treating bone deficit conditions | |
AU5439996A (en) | Compositions and methods for treating pain | |
HU9502724D0 (en) | Methods and compositions for controlling plant development | |
AU5404094A (en) | Method for controlling o-desulfation of heparin and compositions produced thereby | |
ZA96737B (en) | Cosmetic compositions for reducing or preventing signs of cullulite | |
AU4751296A (en) | Method of suspending inclusions and compositions produced thereby | |
AU6485996A (en) | Methods and compositions for modulation and inhibition of teomerase | |
GB9508791D0 (en) | Compositions of matter | |
EP0777473A4 (en) | Compositions and methods for the control of smoking | |
AU3117600A (en) | Composition and method for regulation of body weight and associated conditions | |
PL324461A1 (en) | Synergic herbicidal composition and method of using same | |
GB9521991D0 (en) | Underarm compositions | |
HUP9801629A3 (en) | Methods and compositions for regulation of cd28 expression | |
AU4468093A (en) | Composition and methods for the generation of bone | |
HUP9603529A3 (en) | Femoral part of hip-joint-prothesis | |
GB9507297D0 (en) | New composition of matter | |
IL110887A0 (en) | Method for regulation of NF-AlphaB | |
GB9517111D0 (en) | Surface-coating composition and method of application | |
IL113057A0 (en) | Compositions for the treatment of dandruff | |
ZA963073B (en) | Coating compositions and methods of using them | |
GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
CZ250097A3 (en) | Processes and compositions for regulation of cd28 expression | |
ZA963825B (en) | Composition of matter |